{
  "title": "Primeras convulsiones, convulsiones repetitivas agudas y estado epiléptico",
  "guid": "0028E65D4014C6812EB86030",
  "filepath": "/sessions/bold-jolly-cerf/mnt/Dropbox/- Esquemas/- Entidades clínicas/Neurología/Continuum. Primeras convulsiones, convulsiones repetitivas agudas y estado epiléptico-2025-1.smmx",
  "root": {
    "id": "0",
    "parent": "-1",
    "text": "Primeras convulsiones, convulsiones\nrepetitivas agudas y estado epiléptico",
    "guid": "SZEXMga7Hfo4aTngH3LVsQ",
    "children": [
      {
        "id": "1",
        "parent": "0",
        "text": "# Tratamiento de Emergencia\npara Crisis Epilépticas",
        "guid": "FZY8cG1mDTYlb0cVZd6WQA",
        "children": [
          {
            "id": "2",
            "parent": "1",
            "text": "## Situaciones que requieren\ntratamiento de emergencia",
            "guid": "",
            "children": [
              {
                "id": "3",
                "parent": "2",
                "text": "- Primera crisis epiléptica",
                "guid": "",
                "children": []
              },
              {
                "id": "4",
                "parent": "2",
                "text": "- Inicio de crisis repetitivas agudas anormales (en racimo)",
                "guid": "Oz5b6U10JcZTjRZ8M-n2Ag",
                "children": []
              },
              {
                "id": "5",
                "parent": "2",
                "text": "- Status epilepticus (obligatorio)",
                "guid": "HzvltV14F6APcBAkNNIiJQ",
                "children": []
              }
            ]
          },
          {
            "id": "6",
            "parent": "1",
            "text": "## Lugares donde pueden\nocurrir emergencias",
            "guid": "",
            "children": [
              {
                "id": "7",
                "parent": "6",
                "text": "- Hogar",
                "guid": "",
                "children": []
              },
              {
                "id": "8",
                "parent": "6",
                "text": "- Espacios públicos",
                "guid": "",
                "children": []
              },
              {
                "id": "9",
                "parent": "6",
                "text": "- Entornos de atención médica",
                "guid": "St4k1jTfVzkasLhlL8rvQA",
                "children": []
              }
            ]
          },
          {
            "id": "10",
            "parent": "1",
            "text": "##\nConsecuencias\npotenciales",
            "guid": "",
            "children": [
              {
                "id": "11",
                "parent": "10",
                "text": "- Complicaciones graves",
                "guid": "",
                "children": []
              },
              {
                "id": "12",
                "parent": "10",
                "text": "- Muerte",
                "guid": "",
                "children": []
              }
            ]
          },
          {
            "id": "13",
            "parent": "1",
            "text": "## Factores que\ndeterminan el\ntratamiento",
            "guid": "",
            "children": [
              {
                "id": "14",
                "parent": "13",
                "text": "- Múltiples factores clínicos",
                "guid": "KrMLuR6ZTCsm3vI-UK05Rg",
                "children": []
              },
              {
                "id": "15",
                "parent": "13",
                "text": "- Guías publicadas nacionales e internacionales",
                "guid": "KA4zJnpda1BIImlYIbIPWw",
                "children": []
              },
              {
                "id": "16",
                "parent": "13",
                "text": "- Investigación emergente",
                "guid": "",
                "children": []
              }
            ]
          },
          {
            "id": "17",
            "parent": "1",
            "text": "##\nConsideraciones\nadicionales",
            "guid": "",
            "children": [
              {
                "id": "18",
                "parent": "17",
                "text": "- No todas las pruebas diagnósticas están disponibles mundialmente",
                "guid": "cIeFI1iCZxZE0aQvJYS17g",
                "children": []
              },
              {
                "id": "19",
                "parent": "17",
                "text": "- No todos los tratamientos están disponibles mundialmente",
                "guid": "QuKqUTlAG5wL10GjLWvT6g",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "20",
        "parent": "0",
        "text": "# Primera\nCrisis\nEpiléptica",
        "guid": "",
        "children": [
          {
            "id": "21",
            "parent": "20",
            "text": "##\nCaracterísticas\ngenerales",
            "guid": "",
            "children": [
              {
                "id": "22",
                "parent": "21",
                "text": "- Mayoría son autolimitadas",
                "guid": "bcNZiyDiLYlhhhS1KQG1dA",
                "children": []
              },
              {
                "id": "23",
                "parent": "21",
                "text": "- No producen lesiones o efectos duraderos evidentes",
                "guid": "blZTTzUTKzJc66t2DZI5BA",
                "children": []
              },
              {
                "id": "24",
                "parent": "21",
                "text": "- Pueden ocurrir lesiones físicas",
                "guid": "EotC0mxbu5pCZFspXWlnqA",
                "children": []
              },
              {
                "id": "25",
                "parent": "21",
                "text": "- Riesgo de muerte 2-3 veces mayor que en controles emparejados",
                "guid": "ITsS1F0VE44NNFbpS-4ejQ",
                "children": []
              },
              {
                "id": "26",
                "parent": "21",
                "text": "- Crisis con alteración de la conciencia requiere restricción de privilegios de conducir",
                "guid": "e65fuTQTSSccm1fUI7yS4A",
                "children": []
              }
            ]
          },
          {
            "id": "27",
            "parent": "20",
            "text": "## Estadísticas\nde recurrencia",
            "guid": "",
            "children": [
              {
                "id": "28",
                "parent": "27",
                "text": "- Riesgo acumulado\nde segunda crisis",
                "guid": "",
                "children": [
                  {
                    "id": "29",
                    "parent": "28",
                    "text": "- 29% al año",
                    "guid": "",
                    "children": []
                  },
                  {
                    "id": "30",
                    "parent": "28",
                    "text": "- 37% a los 2 años",
                    "guid": "",
                    "children": []
                  },
                  {
                    "id": "31",
                    "parent": "28",
                    "text": "- 43% a los 5 años",
                    "guid": "",
                    "children": []
                  },
                  {
                    "id": "32",
                    "parent": "28",
                    "text": "- 46% a los 10 años",
                    "guid": "",
                    "children": []
                  }
                ]
              },
              {
                "id": "33",
                "parent": "27",
                "text": "- Tras segunda crisis,\nriesgo de tercera crisis",
                "guid": "",
                "children": [
                  {
                    "id": "34",
                    "parent": "33",
                    "text": "- 57% al año",
                    "guid": "",
                    "children": []
                  },
                  {
                    "id": "35",
                    "parent": "33",
                    "text": "- 63% a los 2 años",
                    "guid": "",
                    "children": []
                  },
                  {
                    "id": "36",
                    "parent": "33",
                    "text": "- 71% a los 5 años",
                    "guid": "",
                    "children": []
                  }
                ]
              },
              {
                "id": "37",
                "parent": "27",
                "text": "- Duración de\nprimera crisis",
                "guid": "",
                "children": [
                  {
                    "id": "38",
                    "parent": "37",
                    "text": "- 50% duran 5 minutos o más",
                    "guid": "LnC0d2S9wSxFbqI7Hvg5mw",
                    "children": []
                  },
                  {
                    "id": "39",
                    "parent": "37",
                    "text": "- 12% duran 30 minutos o más (status epilepticus)",
                    "guid": "PUAoQgpARmpEfO-JACLSlA",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "40",
            "parent": "20",
            "text": "## Tratamiento",
            "guid": "",
            "children": [
              {
                "id": "41",
                "parent": "40",
                "text": "### Estudios históricos",
                "guid": "",
                "children": [
                  {
                    "id": "42",
                    "parent": "41",
                    "text": "- 1989: Ensayo canadiense (pequeño) mostró eficacia de carbamazepina",
                    "guid": "Q4BiBlBUMSwtjqZ-MUO7kQ",
                    "children": []
                  },
                  {
                    "id": "43",
                    "parent": "41",
                    "text": "- 1993: First Seizure\nTrial Group (Italia)",
                    "guid": "",
                    "children": [
                      {
                        "id": "44",
                        "parent": "43",
                        "text": "- 397 niños y adultos",
                        "guid": "",
                        "children": []
                      },
                      {
                        "id": "45",
                        "parent": "43",
                        "text": "- Reducción significativa: 25% recurrencia en tratados vs 51% en no tratados",
                        "guid": "cTZetQ8UuzRaRXEFX4yyBA",
                        "children": []
                      },
                      {
                        "id": "46",
                        "parent": "43",
                        "text": "- Factores de riesgo: edad <16 años (2x) y descargas epileptiformes (1.7x)",
                        "guid": "RCfmZjcxHHttHusIVrMpOA",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "47",
                    "parent": "41",
                    "text": "- 1996: Estudio israelí (91 adultos)",
                    "guid": "I4zYFi-DRjE0HJDgRMfq6g",
                    "children": [
                      {
                        "id": "48",
                        "parent": "47",
                        "text": "- Reducción 3x del riesgo de recurrencia con medicación",
                        "guid": "DJhZwEFQ58kQtgl3CEa5eQ",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "49",
                "parent": "40",
                "text": "### Niños",
                "guid": "",
                "children": [
                  {
                    "id": "50",
                    "parent": "49",
                    "text": "- Parámetros AAN, American Epilepsy Society y Child Neurology Society (2000, 2003)",
                    "guid": "dWQw8S1RYUssA0xZI9TlaA",
                    "children": []
                  },
                  {
                    "id": "51",
                    "parent": "49",
                    "text": "- Conclusiones",
                    "guid": "",
                    "children": [
                      {
                        "id": "52",
                        "parent": "51",
                        "text": "- Riesgo de segunda crisis: 14-65% primer año",
                        "guid": "Eg8ieHFx7pRCzR8DT09Kug",
                        "children": []
                      },
                      {
                        "id": "53",
                        "parent": "51",
                        "text": "- Crisis múltiples recurrentes en minoría de niños",
                        "guid": "e7I0_gdKDoxPch1OPzKXBQ",
                        "children": []
                      },
                      {
                        "id": "54",
                        "parent": "51",
                        "text": "- Mayor riesgo con condición cerebral previa o EEG anormal",
                        "guid": "V54_uX0Aw81wdlKWSNSebg",
                        "children": []
                      },
                      {
                        "id": "55",
                        "parent": "51",
                        "text": "- Medicación disminuye riesgo de segunda crisis",
                        "guid": "DBV_AUq7w5woYVBzUD1lZw",
                        "children": []
                      },
                      {
                        "id": "56",
                        "parent": "51",
                        "text": "- Pocos datos específicos para niños",
                        "guid": "AezgFxWAO3sm8I6fJXm4LQ",
                        "children": []
                      },
                      {
                        "id": "57",
                        "parent": "51",
                        "text": "- No evidencia de mejora en remisión a largo plazo",
                        "guid": "RQOBrVsNH39qQaMXUZvbbQ",
                        "children": []
                      },
                      {
                        "id": "58",
                        "parent": "51",
                        "text": "- Medicamentos antiguos: riesgo significativo de efectos adversos",
                        "guid": "HF4HSXr3rI9Z4pTmEcI4Og",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "59",
                "parent": "40",
                "text": "### Adultos",
                "guid": "",
                "children": [
                  {
                    "id": "60",
                    "parent": "59",
                    "text": "- Guía AAN y American Epilepsy Society (2015)",
                    "guid": "KEkN2gXl4UA1lx2iOlgwUg",
                    "children": []
                  },
                  {
                    "id": "61",
                    "parent": "59",
                    "text": "- Conclusiones",
                    "guid": "",
                    "children": [
                      {
                        "id": "62",
                        "parent": "61",
                        "text": "- Mayor riesgo de recurrencia en primeros 2 años (21-45%)",
                        "guid": "d1fP1HhkPKYJp3sNcwoE0w",
                        "children": []
                      },
                      {
                        "id": "63",
                        "parent": "61",
                        "text": "- Riesgo duplicado con: lesión cerebral previa, EEG anormal, anomalías en neuroimagen, crisis nocturna",
                        "guid": "f65LMlkZmFsyPJvYV0yK6w",
                        "children": []
                      },
                      {
                        "id": "64",
                        "parent": "61",
                        "text": "- Tratamiento inmediato reduce riesgo a corto plazo",
                        "guid": "VhpcKCKy7m4gISlaYi_bKQ",
                        "children": []
                      },
                      {
                        "id": "65",
                        "parent": "61",
                        "text": "- Sin mejora en calidad de vida",
                        "guid": "bW6yCkiCec0ybUCQb1uSIg",
                        "children": []
                      },
                      {
                        "id": "66",
                        "parent": "61",
                        "text": "- Sin mejora en pronóstico a largo plazo (>3 años)",
                        "guid": "XgK1SFldzy8U1UpPIwY29Q",
                        "children": []
                      },
                      {
                        "id": "67",
                        "parent": "61",
                        "text": "- Riesgo de efectos adversos: 7-31% (principalmente leves y reversibles)",
                        "guid": "NGrur38W7Wd0ohJiUMj1-A",
                        "children": []
                      },
                      {
                        "id": "68",
                        "parent": "61",
                        "text": "- Recomendaciones individualizadas según riesgo/beneficio y preferencias del paciente",
                        "guid": "eg6Z9k6Ep0liiy4yIlen0A",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "69",
                "parent": "40",
                "text": "### Investigación reciente",
                "guid": "",
                "children": [
                  {
                    "id": "70",
                    "parent": "69",
                    "text": "- Crisis durante el sueño duplica riesgo de recurrencia (principalmente durante el sueño)",
                    "guid": "VGqIiRgiS9Rcr9gjS8JYXQ",
                    "children": []
                  },
                  {
                    "id": "71",
                    "parent": "69",
                    "text": "- Estudio de Pang\n(1278 pacientes)",
                    "guid": "",
                    "children": [
                      {
                        "id": "72",
                        "parent": "71",
                        "text": "- Razón de riesgo 3.06 para muerte tras primera crisis",
                        "guid": "EIaIemZXUzA-zF0wEDTTrQ",
                        "children": []
                      },
                      {
                        "id": "73",
                        "parent": "71",
                        "text": "- ~10 años de vida potencial perdida",
                        "guid": "P3Dri3EI-QhngV6YFYtHtA",
                        "children": []
                      },
                      {
                        "id": "74",
                        "parent": "71",
                        "text": "- Causa neurológica subyacente: factor de riesgo fuerte",
                        "guid": "E7vndweih_J3uyLdASqZgQ",
                        "children": []
                      },
                      {
                        "id": "75",
                        "parent": "71",
                        "text": "- Segunda crisis no aumentó significativamente riesgo de muerte",
                        "guid": "UCUBvyooY25whiujLie3CA",
                        "children": []
                      },
                      {
                        "id": "76",
                        "parent": "71",
                        "text": "- Tratamiento no redujo riesgo de mortalidad",
                        "guid": "A4YynQVbdfNRLe39N_EhTA",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "77",
                    "parent": "69",
                    "text": "- Pruebas diagnósticas",
                    "guid": "",
                    "children": [
                      {
                        "id": "78",
                        "parent": "77",
                        "text": "- RM superior a TC (detecta lesiones epileptogénicas en 25% de pacientes)",
                        "guid": "BHJjWkXQAGAIuhdEfoD9UA",
                        "children": []
                      },
                      {
                        "id": "79",
                        "parent": "77",
                        "text": "- EEG ambulatorio 24h o video-EEG: diagnóstico más preciso",
                        "guid": "FFSnqWtFRXYg2KUgaL8wMg",
                        "children": []
                      },
                      {
                        "id": "80",
                        "parent": "77",
                        "text": "- Pruebas avanzadas no disponibles en todas regiones",
                        "guid": "A2eRS32IfUM0gYiPE-4ZxQ",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "81",
                    "parent": "69",
                    "text": "- Modelo de\ndecisión Markov\n(IA)",
                    "guid": "",
                    "children": [
                      {
                        "id": "82",
                        "parent": "81",
                        "text": "- Favorece tratamiento inmediato en 2 de 3 escenarios",
                        "guid": "Y9_Qc3NN5cAkIu1yI1C7_w",
                        "children": []
                      },
                      {
                        "id": "83",
                        "parent": "81",
                        "text": "- Simula maximización de años de vida ajustados por calidad",
                        "guid": "ZFbeyAukTAs43AOzeBLGPw",
                        "children": []
                      },
                      {
                        "id": "84",
                        "parent": "81",
                        "text": "- IA probablemente asistirá decisiones clínicas futuras",
                        "guid": "E0bT_TCXJpB5PV_BY2vVvQ",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "id": "85",
        "parent": "0",
        "text": "# Crisis\nRepetitivas\nAgudas",
        "guid": "ZOzKanXTtIAD6JPFdxQC_g",
        "children": [
          {
            "id": "86",
            "parent": "85",
            "text": "## Contexto de aparición",
            "guid": "",
            "children": [
              {
                "id": "87",
                "parent": "86",
                "text": "- Principalmente en entorno ambulatorio",
                "guid": "Wr-J_mnDi2QRk4zFXkW8nA",
                "children": []
              },
              {
                "id": "88",
                "parent": "86",
                "text": "- También en entorno hospitalario",
                "guid": "bx8BV2LBesIWNt3oc5FksQ",
                "children": []
              },
              {
                "id": "89",
                "parent": "86",
                "text": "- Conocidas como \"racimos de crisis\" (seizure clusters)",
                "guid": "KJF7Ih7w9S1yEmIBPOYiyw",
                "children": []
              }
            ]
          },
          {
            "id": "90",
            "parent": "85",
            "text": "## Tipos de crisis\nen racimos",
            "guid": "",
            "children": [
              {
                "id": "91",
                "parent": "90",
                "text": "- Crisis focales con conciencia preservada",
                "guid": "CjY6oxLrByIlpVL9DZ3L7g",
                "children": []
              },
              {
                "id": "92",
                "parent": "90",
                "text": "- Crisis focales con alteración de conciencia",
                "guid": "EHOEZVom240hi-W0dFNU2Q",
                "children": []
              },
              {
                "id": "93",
                "parent": "90",
                "text": "- Crisis focales con evolución a tónico-clónicas bilaterales",
                "guid": "TXTBTUWu0yYXpBDYMcugFQ",
                "children": []
              },
              {
                "id": "94",
                "parent": "90",
                "text": "- Crisis generalizadas",
                "guid": "",
                "children": [
                  {
                    "id": "95",
                    "parent": "94",
                    "text": "- Ausencias",
                    "guid": "",
                    "children": []
                  },
                  {
                    "id": "96",
                    "parent": "94",
                    "text": "- Mioclónicas",
                    "guid": "",
                    "children": []
                  },
                  {
                    "id": "97",
                    "parent": "94",
                    "text": "- Atónicas",
                    "guid": "",
                    "children": []
                  },
                  {
                    "id": "98",
                    "parent": "94",
                    "text": "- Tónico-clónicas",
                    "guid": "",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "99",
            "parent": "85",
            "text": "## Patrón típico",
            "guid": "",
            "children": [
              {
                "id": "100",
                "parent": "99",
                "text": "- Múltiples crisis en 24 horas o pocos días",
                "guid": "UVMfMVCAFIsp3mZVZJnzLw",
                "children": []
              },
              {
                "id": "101",
                "parent": "99",
                "text": "- Seguido por días sin crisis o con crisis únicas aleatorias",
                "guid": "ARc7GyMbxhZIBcjsW9bFGg",
                "children": []
              },
              {
                "id": "102",
                "parent": "99",
                "text": "- Patrón recurrente en ciclo infradiano (multidía)",
                "guid": "DN9RelmZVbE6HIG2e_5S0g",
                "children": [
                  {
                    "id": "103",
                    "parent": "102",
                    "text": "- Ejemplo: ciclo mensual",
                    "guid": "",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "104",
            "parent": "85",
            "text": "##\nDesencadenantes\ncomunes",
            "guid": "",
            "children": [
              {
                "id": "105",
                "parent": "104",
                "text": "- Falta de adherencia a medicación antiepiléptica",
                "guid": "PFrQc1BTX55vj7eDZOxLlg",
                "children": []
              },
              {
                "id": "106",
                "parent": "104",
                "text": "- Enfermedades intercurrentes",
                "guid": "b0RUy2GiGYUh0m5heXqPbw",
                "children": []
              },
              {
                "id": "107",
                "parent": "104",
                "text": "- Privación de sueño",
                "guid": "",
                "children": []
              },
              {
                "id": "108",
                "parent": "104",
                "text": "- Uso de drogas ilícitas",
                "guid": "",
                "children": []
              },
              {
                "id": "109",
                "parent": "104",
                "text": "- Consumo excesivo de alcohol",
                "guid": "IZ6c7CikQRF5U_nlbxNeOQ",
                "children": []
              },
              {
                "id": "110",
                "parent": "104",
                "text": "- Ciclo menstrual",
                "guid": "dI0gp0d3wV8HGFtdBQClDA",
                "children": []
              }
            ]
          },
          {
            "id": "111",
            "parent": "85",
            "text": "## Tratamiento de\ncrisis en racimo",
            "guid": "",
            "children": [
              {
                "id": "112",
                "parent": "111",
                "text": "### Factores para\ndeterminar intervención",
                "guid": "",
                "children": [
                  {
                    "id": "113",
                    "parent": "112",
                    "text": "- Experiencia subjetiva con patrón histórico de crisis",
                    "guid": "blMUOBD4Cr0g3v5OP6YzaQ",
                    "children": []
                  },
                  {
                    "id": "114",
                    "parent": "112",
                    "text": "- Calendarios de crisis a largo plazo (objetivos)",
                    "guid": "YXgfSEq9ZKMkQCaYYo9aZA",
                    "children": []
                  },
                  {
                    "id": "115",
                    "parent": "112",
                    "text": "- Más allá del número\nabsoluto de crisis",
                    "guid": "",
                    "children": [
                      {
                        "id": "116",
                        "parent": "115",
                        "text": "- Intensidad, gravedad y tipo de crisis",
                        "guid": "bdkquWxF74Q-Zh9-erh8NA",
                        "children": []
                      },
                      {
                        "id": "117",
                        "parent": "115",
                        "text": "- Recuperación de conciencia entre crisis",
                        "guid": "Rd9FNXiCoTR2ts8GAjoVqQ",
                        "children": []
                      },
                      {
                        "id": "118",
                        "parent": "115",
                        "text": "- Presencia de fiebre o enfermedad",
                        "guid": "SNYA0mZGholnJmE_OBpVng",
                        "children": []
                      },
                      {
                        "id": "119",
                        "parent": "115",
                        "text": "- Lesiones por crisis",
                        "guid": "",
                        "children": []
                      },
                      {
                        "id": "120",
                        "parent": "115",
                        "text": "- Intervalos entre crisis aumentando o disminuyendo",
                        "guid": "R-igDgj4z6AxlOUNPHXAtQ",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "121",
                "parent": "111",
                "text": "### Opciones de\ntratamiento",
                "guid": "",
                "children": [
                  {
                    "id": "122",
                    "parent": "121",
                    "text": "- Dosis adicionales de medicamentos antiepilépticos habituales",
                    "guid": "UHCQ_zitQGpBdmXCcg8t6w",
                    "children": []
                  },
                  {
                    "id": "123",
                    "parent": "121",
                    "text": "- Benzodiazepinas orales",
                    "guid": "",
                    "children": [
                      {
                        "id": "124",
                        "parent": "123",
                        "text": "- Limitación: absorción en yeyuno",
                        "guid": "YVGBfDrKX6dhIowkT6SVtA",
                        "children": []
                      },
                      {
                        "id": "125",
                        "parent": "123",
                        "text": "- 60-90 minutos hasta concentración máxima",
                        "guid": "S8JqZQIBinMPSskdLTqJrQ",
                        "children": []
                      },
                      {
                        "id": "126",
                        "parent": "123",
                        "text": "- Más retraso si se toma después de comer",
                        "guid": "TL7vFjOK77YPyeQROpgZ0A",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "127",
                    "parent": "121",
                    "text": "### Dispositivos aprobados\npor FDA (EE.UU.)",
                    "guid": "MeUgq1gishkaiSnjEzaiJw",
                    "children": [
                      {
                        "id": "128",
                        "parent": "127",
                        "text": "- Diazepam rectal",
                        "guid": "",
                        "children": [
                          {
                            "id": "129",
                            "parent": "128",
                            "text": "- Dosificación según peso y edad: 2.5-20 mg",
                            "guid": "H9DfOk4wA481UJYEZbAkcA",
                            "children": []
                          }
                        ]
                      },
                      {
                        "id": "130",
                        "parent": "127",
                        "text": "- Diazepam intranasal",
                        "guid": "",
                        "children": [
                          {
                            "id": "131",
                            "parent": "130",
                            "text": "- Dosificación según peso y edad: 5-20 mg",
                            "guid": "RrKkwywHZQpn6joZD4illg",
                            "children": []
                          }
                        ]
                      },
                      {
                        "id": "132",
                        "parent": "127",
                        "text": "- Midazolam intranasal: 5 mg",
                        "guid": "Ek3rk08Qm1hHovs0WjaLog",
                        "children": []
                      },
                      {
                        "id": "133",
                        "parent": "127",
                        "text": "- Autoinyector intramuscular de midazolam: 10 mg",
                        "guid": "WAlq-Hk34EEWrExXKHn7-A",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "134",
                    "parent": "121",
                    "text": "###\nConsideraciones\nimportantes",
                    "guid": "",
                    "children": [
                      {
                        "id": "135",
                        "parent": "134",
                        "text": "- Usar edad y peso para determinar dosis correcta",
                        "guid": "Eu0RwXurtghi2zfbXq98Jg",
                        "children": []
                      },
                      {
                        "id": "136",
                        "parent": "134",
                        "text": "- Dosis insuficientes pueden no detener crisis y llevar a status epilepticus",
                        "guid": "fa1Ae3ImAPkL6gXTSmwvkQ",
                        "children": []
                      },
                      {
                        "id": "137",
                        "parent": "134",
                        "text": "- Desarrollar plan de rescate individualizado por escrito",
                        "guid": "JbDwrxuz6eUFBElhRYHP6Q",
                        "children": []
                      },
                      {
                        "id": "138",
                        "parent": "134",
                        "text": "- Llamar a servicios de\nemergencia si:",
                        "guid": "",
                        "children": [
                          {
                            "id": "139",
                            "parent": "138",
                            "text": "- Crisis no se detienen",
                            "guid": "",
                            "children": []
                          },
                          {
                            "id": "140",
                            "parent": "138",
                            "text": "- Crisis se vuelven más frecuentes o severas",
                            "guid": "aePtdDpU32UrMfRZMJaSOA",
                            "children": []
                          },
                          {
                            "id": "141",
                            "parent": "138",
                            "text": "- Causan lesiones",
                            "guid": "",
                            "children": []
                          },
                          {
                            "id": "142",
                            "parent": "138",
                            "text": "- Compromiso respiratorio",
                            "guid": "",
                            "children": []
                          },
                          {
                            "id": "143",
                            "parent": "138",
                            "text": "- Nivel de conciencia deprimido entre crisis",
                            "guid": "ZlxEbxMcLnJAHzfOeKowAw",
                            "children": []
                          }
                        ]
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "id": "144",
            "parent": "85",
            "text": "## Situaciones especiales",
            "guid": "",
            "children": [
              {
                "id": "145",
                "parent": "144",
                "text": "- Pueden ocurrir como primera crisis no provocada",
                "guid": "YizJygfCMwJS4LulOjY0ww",
                "children": [
                  {
                    "id": "146",
                    "parent": "145",
                    "text": "- Mayor riesgo de muerte en años posteriores",
                    "guid": "APoTQ2mNB_xisDC7Mt8z7g",
                    "children": []
                  }
                ]
              },
              {
                "id": "147",
                "parent": "144",
                "text": "- En entorno hospitalario",
                "guid": "",
                "children": [
                  {
                    "id": "148",
                    "parent": "147",
                    "text": "- Patrones de crisis electroencefalográficas (subclínicas)",
                    "guid": "Qa-6Fn05Wp5GFdYWVJzL1w",
                    "children": []
                  },
                  {
                    "id": "149",
                    "parent": "147",
                    "text": "- Contextos:",
                    "guid": "",
                    "children": [
                      {
                        "id": "150",
                        "parent": "149",
                        "text": "- Status epilepticus no convulsivo",
                        "guid": "eOUQpijxDfEzTEf9dpJRIQ",
                        "children": []
                      },
                      {
                        "id": "151",
                        "parent": "149",
                        "text": "- Encefalopatía hipóxico-isquémica",
                        "guid": "GxcO6j82TdBA_oCzQMf_mQ",
                        "children": []
                      },
                      {
                        "id": "152",
                        "parent": "149",
                        "text": "- Después de retirada de medicación en monitorización video-EEG",
                        "guid": "Wuo3tUYCyhQGSc-DRM4lKg",
                        "children": []
                      },
                      {
                        "id": "153",
                        "parent": "149",
                        "text": "- Otros estados encefalopatía",
                        "guid": "AFepejF7w9x1ZLdiZrPt6Q",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "154",
                    "parent": "147",
                    "text": "- Tratamiento depende de etiología y medicamentos que ya recibe el paciente",
                    "guid": "RJfyTzWD7zBfXh3sJsS8GQ",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "id": "155",
        "parent": "0",
        "text": "# Estado Epiléptico",
        "guid": "aokpmTSDPe4VCuvlNBpAyw",
        "children": [
          {
            "id": "156",
            "parent": "155",
            "text": "## Historia",
            "guid": "PUYiMjI-2ZFg-vDcPkA1dQ",
            "children": [
              {
                "id": "157",
                "parent": "156",
                "text": "- Descrito hace más de 3 milenios",
                "guid": "G8vhjkOrIZdxH2ljXXubpA",
                "children": []
              },
              {
                "id": "158",
                "parent": "156",
                "text": "- Primera descripción: Esagil-kin-apli (Babilonia, 1067-1046 AEC)",
                "guid": "QOR8Njc1P3kyGGd7OcmM3A",
                "children": []
              },
              {
                "id": "159",
                "parent": "156",
                "text": "- Término \"status epilepticus\" origen: \"L' état de mal épileptique\" (Louis Calmiel, 1824)",
                "guid": "YCZNa2Vkr3gwW93-ez1cVQ",
                "children": []
              }
            ]
          },
          {
            "id": "160",
            "parent": "155",
            "text": "## Definición actual\n(ILAE 2015)",
            "guid": "JJr9SHFaXrE8BVvvf4U0_g",
            "children": [
              {
                "id": "161",
                "parent": "160",
                "text": "- \"Condición resultante del fracaso de mecanismos de terminación de crisis\"",
                "guid": "N10oxUJPK3JEU1ooN7TSPw",
                "children": []
              },
              {
                "id": "162",
                "parent": "160",
                "text": "- \"O de la iniciación de mecanismos que conducen a crisis anormalmente prolongadas\"",
                "guid": "c8rvTjm4EYoeaMApOGLhnQ",
                "children": []
              },
              {
                "id": "163",
                "parent": "160",
                "text": "- Dos dimensiones\noperativas:",
                "guid": "bzwAun3G3hVfJ523LIIi7A",
                "children": [
                  {
                    "id": "164",
                    "parent": "163",
                    "text": "- t1 (5 min): Punto más allá del cual se considera \"actividad convulsiva continua\"",
                    "guid": "MAW3p0AijpNqwlhhS9GZNQ",
                    "children": []
                  },
                  {
                    "id": "165",
                    "parent": "163",
                    "text": "- t2 (30 min): Punto más allá del cual hay\nriesgo de consecuencias a largo plazo",
                    "guid": "A82wK1vhwcQpTTTZRLIsYQ",
                    "children": [
                      {
                        "id": "166",
                        "parent": "165",
                        "text": "- Muerte neuronal",
                        "guid": "ExcBPltlnFR-e7k9cz1OqQ",
                        "children": []
                      },
                      {
                        "id": "167",
                        "parent": "165",
                        "text": "- Lesión neuronal",
                        "guid": "QMpLzC7Xlztueqr-ZWVJFA",
                        "children": []
                      },
                      {
                        "id": "168",
                        "parent": "165",
                        "text": "- Alteración de redes neuronales",
                        "guid": "IDH17CqABu1k6n4SV48esg",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "id": "169",
            "parent": "155",
            "text": "## Clasificación",
            "guid": "bM8yXyk92DoPQ_DxYJohrg",
            "children": [
              {
                "id": "170",
                "parent": "169",
                "text": "### Por ejes",
                "guid": "K_2xOX9CxV9LrHd3bMf9BQ",
                "children": [
                  {
                    "id": "171",
                    "parent": "170",
                    "text": "- Semiología (con/sin signos motores prominentes)",
                    "guid": "YvXpxC2ssRoY_QNLUjHqfg",
                    "children": []
                  },
                  {
                    "id": "172",
                    "parent": "170",
                    "text": "- Etiología (causas conocidas/desconocidas)",
                    "guid": "K3OPMHgkoQJ-tA1qW3lG1w",
                    "children": []
                  },
                  {
                    "id": "173",
                    "parent": "170",
                    "text": "- Patrones EEG y características",
                    "guid": "OEcvlml2ZcsnSuAMPBTfwQ",
                    "children": []
                  },
                  {
                    "id": "174",
                    "parent": "170",
                    "text": "- Edad (neonatal, infancia, niñez, adolescencia, adultez, vejez)",
                    "guid": "RVgnkFCYFOUAxwwiWG8ozg",
                    "children": []
                  }
                ]
              },
              {
                "id": "175",
                "parent": "169",
                "text": "### Clasificación simplificada\n(por semiología)",
                "guid": "LhpcmzonInVSLUYZTkxShw",
                "children": [
                  {
                    "id": "176",
                    "parent": "175",
                    "text": "- Estado epiléptico convulsivo",
                    "guid": "ZKcpYzcXxCwl23E5UXZbwg",
                    "children": [
                      {
                        "id": "177",
                        "parent": "176",
                        "text": "- Convulsiones abiertas >5 minutos",
                        "guid": "YFWcZjUfYisyEH1wQ0uGKw",
                        "children": []
                      },
                      {
                        "id": "178",
                        "parent": "176",
                        "text": "- Dos o más crisis tónico-clónicas sin recuperación completa entre ellas",
                        "guid": "YswTRUsNgLwVfXCpDj-idQ",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "179",
                    "parent": "175",
                    "text": "- Estado epiléptico no convulsivo",
                    "guid": "QzIhvhQxfhRpuOlMe3lRVA",
                    "children": [
                      {
                        "id": "180",
                        "parent": "179",
                        "text": "- Crisis de ausencia continuas",
                        "guid": "fafj3xEDyVg3jjEVQwALbw",
                        "children": []
                      },
                      {
                        "id": "181",
                        "parent": "179",
                        "text": "- Crisis focales sensoriales o con alteración de conciencia ≥10 minutos",
                        "guid": "YZvePThVPTcbbzQ9DZmPdg",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "182",
                    "parent": "175",
                    "text": "- Estado epiléptico mioclónico",
                    "guid": "N5gCl2cbq7R6YYx7ZbJfMg",
                    "children": []
                  },
                  {
                    "id": "183",
                    "parent": "175",
                    "text": "- Estado epiléptico motor focal (antes epilepsia partialis continua)",
                    "guid": "IULOKkyO0pUz_rG5Ben3jQ",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "184",
            "parent": "155",
            "text": "## Etapas",
            "guid": "A6aWwVnaIvNXYFNPY_wzJw",
            "children": [
              {
                "id": "185",
                "parent": "184",
                "text": "- Estado epiléptico en desarrollo: Crisis que conducen al estado epiléptico",
                "guid": "DvmFHglw0MAnR7lSccWYYw",
                "children": []
              },
              {
                "id": "186",
                "parent": "184",
                "text": "- Estado epiléptico establecido: >5 minutos, momento de inicio de terapia",
                "guid": "VH5RfDzFKfwABTrZF7BzOg",
                "children": []
              },
              {
                "id": "187",
                "parent": "184",
                "text": "- Estado epiléptico refractario: Continúa a pesar de dos medicamentos anticonvulsivos adecuados",
                "guid": "UPaoEGm-JCUTKcSPTp6L7w",
                "children": []
              },
              {
                "id": "188",
                "parent": "184",
                "text": "- Estado epiléptico super-refractario: Persiste a pesar de medicamentos anestésicos >24 horas",
                "guid": "esHtfkq39aQRnpdfXF3Luw",
                "children": []
              }
            ]
          },
          {
            "id": "189",
            "parent": "155",
            "text": "## Estado Epiléptico\nConvulsivo Establecido",
            "guid": "Aw0y3C0Ny5xp91syOqU1cw",
            "children": [
              {
                "id": "190",
                "parent": "189",
                "text": "### Tratamiento de\nprimera fase",
                "guid": "FCl3UWRY560gV5SlNWxFew",
                "children": [
                  {
                    "id": "191",
                    "parent": "190",
                    "text": "- Adultos >40 kg:",
                    "guid": "MOe6QlRWRl47Vj0INI5RAw",
                    "children": [
                      {
                        "id": "192",
                        "parent": "191",
                        "text": "- Lorazepam 4 mg IV",
                        "guid": "LjBpURK2kFcYioQrPSnubw",
                        "children": []
                      },
                      {
                        "id": "193",
                        "parent": "191",
                        "text": "- Midazolam 10 mg IM",
                        "guid": "HCdhFz_SPX0u74bTcKWykw",
                        "children": []
                      },
                      {
                        "id": "194",
                        "parent": "191",
                        "text": "- Diazepam 10 mg IV",
                        "guid": "fJdneS70wawIViXOTY4PiQ",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "195",
                    "parent": "190",
                    "text": "- Problemas en\npráctica clínica:",
                    "guid": "cnuIoDwjcVsD8nsVDqLptw",
                    "children": [
                      {
                        "id": "196",
                        "parent": "195",
                        "text": "- Subdosificación frecuente (>75% de casos)",
                        "guid": "GLLl0Rt_6l0cLJt5E3TTTw",
                        "children": []
                      },
                      {
                        "id": "197",
                        "parent": "195",
                        "text": "- Consecuencias negativas\nde subdosificación:",
                        "guid": "ZjfgAS3LMthv0p8LaUUS3Q",
                        "children": [
                          {
                            "id": "198",
                            "parent": "197",
                            "text": "1. Falsa creencia de evitar depresión respiratoria",
                            "guid": "Wtj-dFnJ-j0j6khQbwJ1xQ",
                            "children": []
                          },
                          {
                            "id": "199",
                            "parent": "197",
                            "text": "2. Menor eficacia para detener el estado epiléptico",
                            "guid": "PiLh6kRB3PUkbrtAbwqcLQ",
                            "children": []
                          },
                          {
                            "id": "200",
                            "parent": "197",
                            "text": "3. Retrasos en tratamiento asociados con peores resultados (incluida muerte)",
                            "guid": "GJgjVF_E-EgjmO0wRsiMpQ",
                            "children": []
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "id": "201",
                "parent": "189",
                "text": "### Tratamiento de\nsegunda fase",
                "guid": "ZITyoD4a76lfQI5HYHqheQ",
                "children": [
                  {
                    "id": "202",
                    "parent": "201",
                    "text": "- Dosis de carga IV para\nniños y adultos:",
                    "guid": "e_Wu2TLiAeh_SJxLeI0WUg",
                    "children": [
                      {
                        "id": "203",
                        "parent": "202",
                        "text": "- Fosfenitoína 20 mg equivalentes fenitoína/kg",
                        "guid": "YdbDlAeewhlGGyXceompZQ",
                        "children": []
                      },
                      {
                        "id": "204",
                        "parent": "202",
                        "text": "- Ácido valproico 40 mg/kg",
                        "guid": "Ix6sdmJHwVUN_ny1CVaMdw",
                        "children": []
                      },
                      {
                        "id": "205",
                        "parent": "202",
                        "text": "- Levetiracetam 60 mg/kg",
                        "guid": "EBL0LX3RG8Bym59VauvyoQ",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "206",
                    "parent": "201",
                    "text": "- Estudios recientes\n(ESETT):",
                    "guid": "V5sV_RaF56VZ7mhnFb335w",
                    "children": [
                      {
                        "id": "207",
                        "parent": "206",
                        "text": "- Eficacia similar: Levetiracetam (47%), Fosfenitoína (45%), Ácido valproico (46%)",
                        "guid": "WsfEm35dI6cEyJQUc1_n7w",
                        "children": []
                      },
                      {
                        "id": "208",
                        "parent": "206",
                        "text": "- Sin diferencias en nivel de conciencia o eventos adversos graves",
                        "guid": "XiIb8ChhgUU6KHSUUJ2kkA",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "209",
                "parent": "189",
                "text": "### Estado Epiléptico\nRefractario",
                "guid": "cPzxkV6JKpJZB7fMUtO1JQ",
                "children": [
                  {
                    "id": "210",
                    "parent": "209",
                    "text": "- Desarrollado en 23-55% de pacientes con estado epiléptico",
                    "guid": "Zifsqx8i3ahNXV6LCUaZIQ",
                    "children": []
                  },
                  {
                    "id": "211",
                    "parent": "209",
                    "text": "- Mortalidad: 15-39% en adultos (menor en niños)",
                    "guid": "AWqe_Vtb20ASnSWZEX2TKg",
                    "children": []
                  },
                  {
                    "id": "212",
                    "parent": "209",
                    "text": "- Retorno a estado neurológico basal: minoría de pacientes",
                    "guid": "WSz3AAU4xO58aYXLMMgM_Q",
                    "children": []
                  },
                  {
                    "id": "213",
                    "parent": "209",
                    "text": "- Factores predictivos\nde mortalidad:",
                    "guid": "G76sk1ZX7jJGhgTkdoZxLg",
                    "children": [
                      {
                        "id": "214",
                        "parent": "213",
                        "text": "- Edad avanzada",
                        "guid": "VLUR2ktOmPlp5lkdMtctyg",
                        "children": []
                      },
                      {
                        "id": "215",
                        "parent": "213",
                        "text": "- Etiología aguda",
                        "guid": "c7AaPiQOzbIDdNJaWDUM3g",
                        "children": []
                      },
                      {
                        "id": "216",
                        "parent": "213",
                        "text": "- Estado epiléptico refractario",
                        "guid": "Yim9W2K1YKE4r65YUyau7Q",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "217",
                "parent": "189",
                "text": "### Tratamiento de tercera fase\n(estado epiléptico refractario)",
                "guid": "N1_TEh2McKVj6KHlBhNw7w",
                "children": [
                  {
                    "id": "218",
                    "parent": "217",
                    "text": "- Opciones comunes:",
                    "guid": "QT6LNBG3ZiQl-mQSJ2Z33w",
                    "children": [
                      {
                        "id": "219",
                        "parent": "218",
                        "text": "- Infusiones continuas de medicamentos anestésicos",
                        "guid": "MNpDzHNXwp0wrREBMkTiyQ",
                        "children": []
                      },
                      {
                        "id": "220",
                        "parent": "218",
                        "text": "- Midazolam, pentobarbital, propofol",
                        "guid": "TrOd3UNKNppDwnXzJ-CU3Q",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "221",
                    "parent": "217",
                    "text": "- Controversia sobre\nefectos adversos:",
                    "guid": "SIL7iEAr-75YqKHaZEGoGw",
                    "children": [
                      {
                        "id": "222",
                        "parent": "221",
                        "text": "- Algunos estudios: mayor riesgo de muerte, infección, discapacidad",
                        "guid": "FoPp8R8upr9ayBlKazj7yw",
                        "children": []
                      },
                      {
                        "id": "223",
                        "parent": "221",
                        "text": "- Otros estudios: coma terapéutico más corto y profundo asociado con menos complicaciones",
                        "guid": "an0_uESucmceECmVXi1Z9g",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "224",
                    "parent": "217",
                    "text": "- Alternativa: medicamentos no\nsedantes adicionales",
                    "guid": "aL1AGSGE--82YmbUSub9dQ",
                    "children": [
                      {
                        "id": "225",
                        "parent": "224",
                        "text": "- Algunos estudios muestran control en >50% de pacientes",
                        "guid": "BDpckG8SFSweDaxiRXjnxA",
                        "children": []
                      },
                      {
                        "id": "226",
                        "parent": "224",
                        "text": "- Evita complicaciones de cuidados intensivos prolongados",
                        "guid": "AMl7UEQIEHRs31-kMaO_HA",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "id": "227",
            "parent": "155",
            "text": "## Estado Epiléptico\nNo Convulsivo",
            "guid": "YNanPyerF9gt9AXNKVmixw",
            "children": [
              {
                "id": "228",
                "parent": "227",
                "text": "- Difícil de diagnosticar, especialmente en ancianos y pacientes sin historia de epilepsia",
                "guid": "Z9cTlwacp6cNm0riflr9iA",
                "children": []
              },
              {
                "id": "229",
                "parent": "227",
                "text": "- Tipos:",
                "guid": "JctOZmhjZCxpk_lTEEiOHg",
                "children": [
                  {
                    "id": "230",
                    "parent": "229",
                    "text": "- Sensorial focal con conciencia preservada",
                    "guid": "LRHWlAekIuhudegUFc8WrQ",
                    "children": []
                  },
                  {
                    "id": "231",
                    "parent": "229",
                    "text": "- Motor focal con conciencia preservada",
                    "guid": "KSke1yTYTulgthQiLWN7Zw",
                    "children": []
                  },
                  {
                    "id": "232",
                    "parent": "229",
                    "text": "- Focal con alteración de conciencia",
                    "guid": "E-pkFX7DwIRy3GMsFLPfZg",
                    "children": []
                  },
                  {
                    "id": "233",
                    "parent": "229",
                    "text": "- Ausencias",
                    "guid": "QsvQ-V-7wtBGV56CeiukCw",
                    "children": []
                  },
                  {
                    "id": "234",
                    "parent": "229",
                    "text": "- Asociado con afasia, nivel de conciencia deprimido o coma",
                    "guid": "fUgzdSpAQGgAPxT6Xh7atA",
                    "children": []
                  }
                ]
              },
              {
                "id": "235",
                "parent": "227",
                "text": "- Características\n(registro SENSE):",
                "guid": "UetYQC4zGscHeH17OcJr1w",
                "children": [
                  {
                    "id": "236",
                    "parent": "235",
                    "text": "- Mediana de edad: 72 años",
                    "guid": "NM_CbxUTyF04HWlfWpsQ1Q",
                    "children": []
                  },
                  {
                    "id": "237",
                    "parent": "235",
                    "text": "- Mortalidad hospitalaria: 19%",
                    "guid": "fXcsiiGxYrJq4570KokDHg",
                    "children": []
                  },
                  {
                    "id": "238",
                    "parent": "235",
                    "text": "- Retraso en diagnóstico: 150 minutos vs 30 minutos en convulsivo",
                    "guid": "KVWFmllZhwhAWBnLUn6kcQ",
                    "children": []
                  },
                  {
                    "id": "239",
                    "parent": "235",
                    "text": "- Factores asociados con\nmenor tiempo hasta cese:",
                    "guid": "fjHV8SEOLe5_4h_ZEhw6Bw",
                    "children": [
                      {
                        "id": "240",
                        "parent": "239",
                        "text": "- Menor puntuación de gravedad",
                        "guid": "H9HucnK-gwUm0BltYp2_aw",
                        "children": []
                      },
                      {
                        "id": "241",
                        "parent": "239",
                        "text": "- Menos comorbilidades",
                        "guid": "UnpF1W0nt-9cyWN2T8J5Sg",
                        "children": []
                      },
                      {
                        "id": "242",
                        "parent": "239",
                        "text": "- Uso de benzodiazepina como tratamiento de primera fase",
                        "guid": "F2f4V10IeHEt4VP-aVNQmA",
                        "children": []
                      },
                      {
                        "id": "243",
                        "parent": "239",
                        "text": "- Dosis acumulativas más altas en primera hora",
                        "guid": "CzuTODVZ0XkjFbxvQAtVpw",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "id": "244",
            "parent": "155",
            "text": "## Estado Epiléptico\nRefractario de Novo (NORSE)",
            "guid": "Sm2Z1lszJc8apmZ9R-TGYA",
            "children": [
              {
                "id": "245",
                "parent": "244",
                "text": "- Presentación clínica, no diagnóstico específico",
                "guid": "fOSIgQWKBXFybcl-JjoOHA",
                "children": []
              },
              {
                "id": "246",
                "parent": "244",
                "text": "- Sin epilepsia activa o trastornos neurológicos preexistentes",
                "guid": "XuOMeTLF40p4uLKNXRViaw",
                "children": []
              },
              {
                "id": "247",
                "parent": "244",
                "text": "- Sin causa estructural, tóxica o metabólica clara",
                "guid": "U9QROHia0mZvMZxyc6X_qg",
                "children": []
              },
              {
                "id": "248",
                "parent": "244",
                "text": "- Síndrome de epilepsia relacionada\ncon infección febril (FIRES):",
                "guid": "a1lVaxYBtd9WQ78WPdObQA",
                "children": [
                  {
                    "id": "249",
                    "parent": "248",
                    "text": "- Subcategoría de NORSE",
                    "guid": "AyltzjMNIowNlhSKGpFmJg",
                    "children": []
                  },
                  {
                    "id": "250",
                    "parent": "248",
                    "text": "- Infección febril previa (2 semanas a 24 horas antes)",
                    "guid": "EBWa_Tt3aIgD5La-G1EuNg",
                    "children": []
                  }
                ]
              },
              {
                "id": "251",
                "parent": "244",
                "text": "- Etiologías\nmás comunes:",
                "guid": "cNE6ASb6cy1bXIPdOz7T2A",
                "children": [
                  {
                    "id": "252",
                    "parent": "251",
                    "text": "- Criptogénica (49.9%)",
                    "guid": "Ai2Y_HYC6loDI5o4fxIhfg",
                    "children": []
                  },
                  {
                    "id": "253",
                    "parent": "251",
                    "text": "- Autoinmune (36.2%)",
                    "guid": "e4zvy3WRY7clTC-aWnB8RQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "254",
                "parent": "244",
                "text": "- Mortalidad: 19-22%",
                "guid": "KFdHAR4E4ic3hd6wfCtYOQ",
                "children": []
              },
              {
                "id": "255",
                "parent": "244",
                "text": "- Tratamiento:",
                "guid": "Fp-0jia3eyJv0VfjAfkJ-Q",
                "children": [
                  {
                    "id": "256",
                    "parent": "255",
                    "text": "- Sin ensayos controlados aleatorios",
                    "guid": "PLkxAUYVFvk_zKU6P-Kezw",
                    "children": []
                  },
                  {
                    "id": "257",
                    "parent": "255",
                    "text": "- Recomendaciones por\nconsenso internacional (2022):",
                    "guid": "LZ8uFivfGPVL5d0CVfZ1Fw",
                    "children": [
                      {
                        "id": "258",
                        "parent": "257",
                        "text": "- Inmunoterapia dentro de 72 horas",
                        "guid": "eSI5hk1iucRadAT1CTfUgw",
                        "children": []
                      },
                      {
                        "id": "259",
                        "parent": "257",
                        "text": "- Inmunoterapia de segunda línea y dietas cetogénicas dentro de 7 días",
                        "guid": "CNoiTV5Yu7MkiQK5eatcTg",
                        "children": []
                      },
                      {
                        "id": "260",
                        "parent": "257",
                        "text": "- Corticosteroides: primera línea (metilprednisolona 20-30 mg/kg/día, máx. 1g)",
                        "guid": "BVMu4X_lhpc06jAmB4DH3Q",
                        "children": []
                      },
                      {
                        "id": "261",
                        "parent": "257",
                        "text": "- Rituximab si se identifica anticuerpo patógeno",
                        "guid": "dehw8TgNyl8GkulbcXVgvQ",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "id": "262",
            "parent": "155",
            "text": "## Estado Epiléptico\nSuper-Refractario",
            "guid": "SeP7HQNru7JSIc1QYIOvqw",
            "children": [
              {
                "id": "263",
                "parent": "262",
                "text": "- Persistencia de crisis >24 horas a pesar de medicamentos anestésicos",
                "guid": "KiM21EHzJTNifLmkZtxn1Q",
                "children": []
              },
              {
                "id": "264",
                "parent": "262",
                "text": "- Múltiples etiologías posibles",
                "guid": "CAg8LSJJXt4mvwakASp1sw",
                "children": []
              },
              {
                "id": "265",
                "parent": "262",
                "text": "- Tratamiento\ndesafiante:",
                "guid": "XymRxHLyp2cWLqU1DMi_2g",
                "children": [
                  {
                    "id": "266",
                    "parent": "265",
                    "text": "- Evidencia insuficiente para: cirugía cerebral, dieta cetogénica, anestesia por inhalación",
                    "guid": "b6wYowEzC5oKYko2eIY68A",
                    "children": []
                  },
                  {
                    "id": "267",
                    "parent": "265",
                    "text": "- Hipotermia terapéutica: posiblemente efectiva en adultos",
                    "guid": "X4vHTS7rTPByMZc-ZN72Lg",
                    "children": []
                  }
                ]
              },
              {
                "id": "268",
                "parent": "262",
                "text": "- Pronóstico (revisión sistemática 2023):",
                "guid": "LtDThycbx2VsX74MJLlEeA",
                "children": [
                  {
                    "id": "269",
                    "parent": "268",
                    "text": "- Duración media: 36.3 días",
                    "guid": "HtHAXWIUgjdivzTxaLW7eg",
                    "children": []
                  },
                  {
                    "id": "270",
                    "parent": "268",
                    "text": "- Solo 26.8% sin discapacidad o discapacidad leve al alta",
                    "guid": "ZYA96TThAkFJOWslD6N0vQ",
                    "children": []
                  },
                  {
                    "id": "271",
                    "parent": "268",
                    "text": "- Mortalidad hospitalaria: 24. 1%",
                    "guid": "dtQndCu2JMl2f9ySftxjoQ",
                    "children": []
                  },
                  {
                    "id": "272",
                    "parent": "268",
                    "text": "- Mayor duración asociada con mayor discapacidad",
                    "guid": "Tf-DqB0-4zcABtlUPaucSw",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "273",
            "parent": "155",
            "text": "## Herramientas\nDiagnósticas",
            "guid": "HnHu0QppI4s2Mdc7ff22Hg",
            "children": [
              {
                "id": "274",
                "parent": "273",
                "text": "### EEG",
                "guid": "OVRweyhjbnli3KxNaCVEAg",
                "children": [
                  {
                    "id": "275",
                    "parent": "274",
                    "text": "- Papel crítico en diagnóstico y manejo",
                    "guid": "T3813k88alkM3oh6LqjHog",
                    "children": []
                  },
                  {
                    "id": "276",
                    "parent": "274",
                    "text": "- Monitorización video-EEG continua esencial",
                    "guid": "Qi8RwCMNLbA7cYd8YQDSHQ",
                    "children": []
                  },
                  {
                    "id": "277",
                    "parent": "274",
                    "text": "- Criterios de Salzburgo: alta precisión diagnóstica para estado epiléptico no convulsivo",
                    "guid": "BSGv5x4wvG1Jto2XaqHt0Q",
                    "children": []
                  }
                ]
              },
              {
                "id": "278",
                "parent": "273",
                "text": "### Neuroimagen",
                "guid": "UxG-rhLv-Lx6RWKOSeXmIw",
                "children": [
                  {
                    "id": "279",
                    "parent": "278",
                    "text": "- Anomalías peri-ictales en RM en 26% de pacientes",
                    "guid": "PqYdhnDFPyFIwknEDKWhLg",
                    "children": []
                  },
                  {
                    "id": "280",
                    "parent": "278",
                    "text": "- Localizaciones anatómicas\nmás comunes:",
                    "guid": "DgQiWEjJIxlKUT15LHYRKQ",
                    "children": [
                      {
                        "id": "281",
                        "parent": "280",
                        "text": "- Corteza cerebral (75%)",
                        "guid": "UzJGpACDFLQqc8dHDIa3Hw",
                        "children": []
                      },
                      {
                        "id": "282",
                        "parent": "280",
                        "text": "- Tálamo (61%)",
                        "guid": "KOaDLQ1Qc5R0q_sheGW5DA",
                        "children": []
                      },
                      {
                        "id": "283",
                        "parent": "280",
                        "text": "- Hipocampo y amígdala (43%)",
                        "guid": "XIzd7QGKg5snDoCuHrvvrg",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "284",
                    "parent": "278",
                    "text": "- Pacientes con\nanomalías en RM:",
                    "guid": "f2Xws2Zqsy4nrwbTDWoTCw",
                    "children": [
                      {
                        "id": "285",
                        "parent": "284",
                        "text": "- Mayor probabilidad de muerte hospitalaria (27% vs 11%)",
                        "guid": "JJexS2KACCt_vMHLKblhMw",
                        "children": []
                      },
                      {
                        "id": "286",
                        "parent": "284",
                        "text": "- Mayor tasa de estado epiléptico refractario (71% vs 33%)",
                        "guid": "ALDEmElzT2MUW08EU8KDRw",
                        "children": []
                      },
                      {
                        "id": "287",
                        "parent": "284",
                        "text": "- Mayor tasa de epilepsia de inicio tardío (40% vs 21%)",
                        "guid": "XGNIHw6gsZIdqGlqGwllpQ",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "288",
                "parent": "273",
                "text": "### Medidas de\npronóstico",
                "guid": "LzPWR3IAREw54CQ0AmYc6w",
                "children": [
                  {
                    "id": "289",
                    "parent": "288",
                    "text": "- Status Epilepticus\nSeverity Score (STESS):",
                    "guid": "HV4eE2yp7ndTdGVFHg7irA",
                    "children": [
                      {
                        "id": "290",
                        "parent": "289",
                        "text": "- Predictores: edad, historia de crisis, tipo de crisis, alteración de conciencia",
                        "guid": "coNZAGRT63wO7NQKG2ncLg",
                        "children": []
                      },
                      {
                        "id": "291",
                        "parent": "289",
                        "text": "- Escala de Coma de Glasgow: útil para pronóstico",
                        "guid": "caRfEAOYzysTz5U6TjE8_g",
                        "children": []
                      },
                      {
                        "id": "292",
                        "parent": "289",
                        "text": "- Puntuación de Ranking modificada: nivel de discapacidad neurológica",
                        "guid": "BSNSxzreFehs7SysKbsEEg",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "id": "293",
        "parent": "0",
        "text": "## Conclusión",
        "guid": "",
        "children": [
          {
            "id": "294",
            "parent": "293",
            "text": "- Necesidad de mejorar aspectos de guías de práctica clínica en estado epiléptico",
            "guid": "dnBl3A95z10tieufddZWjw",
            "children": []
          },
          {
            "id": "295",
            "parent": "293",
            "text": "- Importancia de comprender e implementar\nnuevas guías y técnicas para:",
            "guid": "",
            "children": [
              {
                "id": "296",
                "parent": "295",
                "text": "- Diagnóstico",
                "guid": "",
                "children": []
              },
              {
                "id": "297",
                "parent": "295",
                "text": "- Clasificación",
                "guid": "",
                "children": []
              },
              {
                "id": "298",
                "parent": "295",
                "text": "- Evaluación de pacientes con emergencias convulsivas agudas",
                "guid": "deSCi1U48nMDQGmbJRhY0w",
                "children": []
              }
            ]
          },
          {
            "id": "299",
            "parent": "293",
            "text": "- Los proveedores de salud deben adherirse a guías de tratamiento",
            "guid": "Rzk2vz0gjc8nfnW-ObyPwA",
            "children": []
          },
          {
            "id": "300",
            "parent": "293",
            "text": "- Nuevos medicamentos antiepilépticos\ny técnicas de evaluación deben\nincorporarse al enfoque para:",
            "guid": "",
            "children": [
              {
                "id": "301",
                "parent": "300",
                "text": "- Primeras crisis",
                "guid": "",
                "children": []
              },
              {
                "id": "302",
                "parent": "300",
                "text": "- Crisis repetitivas agudas",
                "guid": "",
                "children": []
              },
              {
                "id": "303",
                "parent": "300",
                "text": "- Diferentes formas de estado epiléptico en niños y adultos",
                "guid": "IXR5SzZrSclVJmvuExjYXA",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "304",
        "parent": "0",
        "text": "## Puntos Clave",
        "guid": "",
        "children": [
          {
            "id": "305",
            "parent": "304",
            "text": "### Primera Crisis",
            "guid": "",
            "children": [
              {
                "id": "306",
                "parent": "305",
                "text": "- Mayor riesgo de recurrencia en primeros 2 años (21-45%)",
                "guid": "OgQY9Gj2AShhShVaPydruw",
                "children": []
              },
              {
                "id": "307",
                "parent": "305",
                "text": "- Riesgo duplicado con:",
                "guid": "",
                "children": [
                  {
                    "id": "308",
                    "parent": "307",
                    "text": "- Evidencia de lesión cerebral previa",
                    "guid": "I9QXEE43QgZo4m_OQTI1JA",
                    "children": []
                  },
                  {
                    "id": "309",
                    "parent": "307",
                    "text": "- EEG con anormalidades epileptiformes",
                    "guid": "OuEwfTxW1RNfQRfQcP5uWA",
                    "children": []
                  },
                  {
                    "id": "310",
                    "parent": "307",
                    "text": "- Anomalía significativa en neuroimagen cerebral",
                    "guid": "JCaJXVESfcMDfvRSGpbvOQ",
                    "children": []
                  },
                  {
                    "id": "311",
                    "parent": "307",
                    "text": "- Crisis nocturna",
                    "guid": "",
                    "children": []
                  }
                ]
              },
              {
                "id": "312",
                "parent": "305",
                "text": "- Razón de riesgo 3.06 para muerte tras primera crisis (~10 años de vida potencial perdida)",
                "guid": "YIxNIDEI3_EQbUXIVnDPqw",
                "children": []
              },
              {
                "id": "313",
                "parent": "305",
                "text": "- EEG ambulatorio 24h o video-EEG permite diagnóstico más preciso",
                "guid": "BkHSZBOtr2N7iSh-TXsJJA",
                "children": []
              },
              {
                "id": "314",
                "parent": "305",
                "text": "- Modelo de decisión Markov e IA: herramientas prometedoras para decisión de tratamiento",
                "guid": "UM49MyMHnj0HN5jkckK2fg",
                "children": []
              }
            ]
          },
          {
            "id": "315",
            "parent": "304",
            "text": "### Crisis\nRepetitivas\nAgudas",
            "guid": "",
            "children": [
              {
                "id": "316",
                "parent": "315",
                "text": "- Deben distinguirse de patrones habituales en ciclos infradianos",
                "guid": "WXLoBlxeBNIFW47aE3cA-g",
                "children": []
              },
              {
                "id": "317",
                "parent": "315",
                "text": "- Desencadenantes\ncomunes:",
                "guid": "",
                "children": [
                  {
                    "id": "318",
                    "parent": "317",
                    "text": "- Falta de adherencia a medicación antiepiléptica",
                    "guid": "RVQF-malpDRSnmy2aSgdCg",
                    "children": []
                  },
                  {
                    "id": "319",
                    "parent": "317",
                    "text": "- Enfermedades intercurrentes",
                    "guid": "NNzmOjuA3IQqWlIub74WuA",
                    "children": []
                  },
                  {
                    "id": "320",
                    "parent": "317",
                    "text": "- Privación de sueño",
                    "guid": "",
                    "children": []
                  },
                  {
                    "id": "321",
                    "parent": "317",
                    "text": "- Uso de drogas ilícitas o consumo excesivo de alcohol",
                    "guid": "d9exlwmbaf5gvIUQG_469A",
                    "children": []
                  },
                  {
                    "id": "322",
                    "parent": "317",
                    "text": "- Ciclo menstrual",
                    "guid": "",
                    "children": []
                  }
                ]
              },
              {
                "id": "323",
                "parent": "315",
                "text": "- Opciones de\ntratamiento (EE.UU.):",
                "guid": "",
                "children": [
                  {
                    "id": "324",
                    "parent": "323",
                    "text": "- Diazepam rectal: 2.5-20 mg según peso/edad",
                    "guid": "Wq3nwWQ7eWI2lSotOzo04Q",
                    "children": []
                  },
                  {
                    "id": "325",
                    "parent": "323",
                    "text": "- Diazepam intranasal: 5-20 mg según peso/edad",
                    "guid": "FURZU0cCb_YRqwSNG4YruA",
                    "children": []
                  },
                  {
                    "id": "326",
                    "parent": "323",
                    "text": "- Midazolam intranasal: 5 mg",
                    "guid": "WrAfWQ00LQtpATTcK35cjA",
                    "children": []
                  },
                  {
                    "id": "327",
                    "parent": "323",
                    "text": "- Autoinyector intramuscular de midazolam: 10 mg",
                    "guid": "MDvLSHA4zcAdwRMLCa6zTg",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "328",
            "parent": "304",
            "text": "### Estado Epiléptico",
            "guid": "",
            "children": [
              {
                "id": "329",
                "parent": "328",
                "text": "- Definición ILAE 2015: condición por fallo de mecanismos de terminación de crisis o inicio de mecanismos de crisis anormalmente prolongadas",
                "guid": "TJbSkiMcoeUdJbRJEerYjA",
                "children": []
              },
              {
                "id": "330",
                "parent": "328",
                "text": "- Etapas:",
                "guid": "",
                "children": [
                  {
                    "id": "331",
                    "parent": "330",
                    "text": "1. En desarrollo: crisis que conducen al estado epiléptico",
                    "guid": "CcJGGm_EIP97EvWWPp8sVA",
                    "children": []
                  },
                  {
                    "id": "332",
                    "parent": "330",
                    "text": "2. Establecido: >5 minutos (punto t1), inicio de terapia",
                    "guid": "K0T9gyVtR8UuXUMMIxyvGg",
                    "children": []
                  },
                  {
                    "id": "333",
                    "parent": "330",
                    "text": "3. Refractario: persistencia tras dos medicamentos adecuados de diferentes clases",
                    "guid": "Lwixww8ZyBw_GuoPCbaZhQ",
                    "children": []
                  },
                  {
                    "id": "334",
                    "parent": "330",
                    "text": "4. Super-refractario: persistencia >24 horas a pesar de medicamentos anestésicos",
                    "guid": "c1VBfnWwFDxE8M5mCJma0g",
                    "children": []
                  }
                ]
              },
              {
                "id": "335",
                "parent": "328",
                "text": "### Tratamiento",
                "guid": "",
                "children": [
                  {
                    "id": "336",
                    "parent": "335",
                    "text": "- Primera fase\n(adultos >40 kg):",
                    "guid": "",
                    "children": [
                      {
                        "id": "337",
                        "parent": "336",
                        "text": "- Lorazepam 4 mg IV",
                        "guid": "",
                        "children": []
                      },
                      {
                        "id": "338",
                        "parent": "336",
                        "text": "- Midazolam 10 mg IM",
                        "guid": "",
                        "children": []
                      },
                      {
                        "id": "339",
                        "parent": "336",
                        "text": "- Diazepam 10 mg IV",
                        "guid": "",
                        "children": []
                      },
                      {
                        "id": "340",
                        "parent": "336",
                        "text": "- Problema común: subdosificación (mayoría de pacientes)",
                        "guid": "PLKEMlab0vMkH8aKF2KjjA",
                        "children": []
                      },
                      {
                        "id": "341",
                        "parent": "336",
                        "text": "- Estado epiléptico no controlado: mayor riesgo de depresión respiratoria que benzodiazepinas",
                        "guid": "Y8___w0g-2ZC4QAYFAvLRw",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "342",
                    "parent": "335",
                    "text": "- Segunda fase:",
                    "guid": "",
                    "children": [
                      {
                        "id": "343",
                        "parent": "342",
                        "text": "- Fosfenitoína 20 mg equivalentes fenitoína/kg IV",
                        "guid": "fVnJJmCiEyMdun6WSfCbuA",
                        "children": []
                      },
                      {
                        "id": "344",
                        "parent": "342",
                        "text": "- Ácido valproico 40 mg/kg IV",
                        "guid": "A761CTrgMt9b23REDYD7Iw",
                        "children": []
                      },
                      {
                        "id": "345",
                        "parent": "342",
                        "text": "- Levetiracetam 60 mg/kg IV",
                        "guid": "KqRT3lbuadpMICd3VelRYQ",
                        "children": []
                      }
                    ]
                  },
                  {
                    "id": "346",
                    "parent": "335",
                    "text": "- Tercera fase (refractario):",
                    "guid": "",
                    "children": [
                      {
                        "id": "347",
                        "parent": "346",
                        "text": "- Opciones: brivaracetam, ketamina, lacosamida, levetiracetam, midazolam, pentobarbital, fenitoína, propofol, ácido valproico",
                        "guid": "fFuxn3p9aoR5BgB7K2RjYw",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "id": "348",
                "parent": "328",
                "text": "### Estado Epiléptico\nNo Convulsivo",
                "guid": "",
                "children": [
                  {
                    "id": "349",
                    "parent": "348",
                    "text": "- Diagnóstico frecuentemente omitido",
                    "guid": "CZcyoDgg6oo1GvzofOx0Hw",
                    "children": []
                  },
                  {
                    "id": "350",
                    "parent": "348",
                    "text": "- Diagnóstico perdido: OR 3.83 para no retorno a línea base funcional",
                    "guid": "LdD-x3oLy04Fhg7xaoOC-Q",
                    "children": []
                  },
                  {
                    "id": "351",
                    "parent": "348",
                    "text": "- Requiere alto índice de sospecha y video-EEG urgente",
                    "guid": "UKeeQiml1XsB5iaFNHeeQQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "352",
                "parent": "328",
                "text": "### NORSE y FIRES",
                "guid": "",
                "children": [
                  {
                    "id": "353",
                    "parent": "352",
                    "text": "- NORSE: presentación clínica sin epilepsia activa previa o trastornos neurológicos relevantes",
                    "guid": "NsbQ4UTHJp5Ig2mINCCaBw",
                    "children": []
                  },
                  {
                    "id": "354",
                    "parent": "352",
                    "text": "- FIRES: subcategoría con infección febril previa (2 semanas a 24 horas antes)",
                    "guid": "JWk5wWY96B5-ETW_KSfuyg",
                    "children": []
                  },
                  {
                    "id": "355",
                    "parent": "352",
                    "text": "- NORSE criptogénico: considerar inmunoterapia dentro de 72 horas",
                    "guid": "IR4a_VnsqgM2qOntS8Ju2w",
                    "children": []
                  },
                  {
                    "id": "356",
                    "parent": "352",
                    "text": "- Inmunoterapia de segunda línea y dietas cetogénicas: considerar dentro de 7 días",
                    "guid": "MNsT3QLJEWUhq8A8LTbFfQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "357",
                "parent": "328",
                "text": "### Estado Epiléptico\nSuper-Refractario",
                "guid": "",
                "children": [
                  {
                    "id": "358",
                    "parent": "357",
                    "text": "- Duración media: 36.3 días",
                    "guid": "fUZ76RqxwLhYmyjgBt2uiQ",
                    "children": []
                  },
                  {
                    "id": "359",
                    "parent": "357",
                    "text": "- Etiologías: eventos cerebrales agudos (41. 6%), causas desconocidas (22.3%)",
                    "guid": "UtKrQg22JcgDyiKoAKOqCQ",
                    "children": []
                  },
                  {
                    "id": "360",
                    "parent": "357",
                    "text": "- Mortalidad hospitalaria: 24. 1%",
                    "guid": "B8HxFglQMZlrJy0DWGmPWA",
                    "children": []
                  },
                  {
                    "id": "361",
                    "parent": "357",
                    "text": "- Solo 26.8% sin discapacidad o discapacidad leve al alta",
                    "guid": "MvYHFG0NU4gM4S2ZabzX9Q",
                    "children": []
                  }
                ]
              },
              {
                "id": "362",
                "parent": "328",
                "text": "### Herramientas\nDiagnósticas",
                "guid": "",
                "children": [
                  {
                    "id": "363",
                    "parent": "362",
                    "text": "- Video-EEG continuo: esencial para visualizar patrones electrofisiológicos",
                    "guid": "MdR6JlVklyId3XH8Vz2z6A",
                    "children": []
                  },
                  {
                    "id": "364",
                    "parent": "362",
                    "text": "- Anomalías peri-ictales en RM en 25% de pacientes",
                    "guid": "ddtRvjcOjKAogwkZJrZlnA",
                    "children": [
                      {
                        "id": "365",
                        "parent": "364",
                        "text": "- Localizaciones: corteza cerebral (75%), tálamo (61%), hipocampo y amígdala (43%)",
                        "guid": "O6J_QBvup7sAZaKyXMCaPg",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ]
  },
  "node_count": 366,
  "relations": [],
  "cross_references": [
    {
      "from_node": "160",
      "reference": "ILAE"
    }
  ],
  "specialty": "Continuum",
  "folder": "- Entidades clínicas/Neurología",
  "filename": "Continuum. Primeras convulsiones, convulsiones repetitivas agudas y estado epiléptico-2025-1",
  "id": "map_1594",
  "resolved_references": []
}